Synapse Open Synapse
Biology

STAT+: Five biotech updates to read after ESMO this weekend

STAT News · · 1 min read

Moderna and Merck are racing to submit their personalized cancer vaccine for FDA approval, expected in 2027, according to Moderna CEO Stéphane Bancel.

Latest from STAT News